Gibbs Wilson, Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1605 South 31st Street, Temple, TX 76508 Phone: 254-215-0100 |
Dr. Dan William Giebel, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 |
Steven Manuel Costa, M. D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 |
Dr. Glen B. Drake, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 |
Vinh Q Nguyen, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 |
Dr. Edwin E. Terry, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 |
Dr. Linley E. Watson, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 |
Dr. Ishwarlal V. Lodhia, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 |
Joseph Albright Stafford, Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 |
News Archive
Robert H. DuRant, Ph.D., and his colleagues studied a public service announcement (PSA) campaign aired recently in North Carolina that conveyed the message, "Talk to your kids about sex. Everyone else is."
"Women's rights are under the greatest attack for almost 20 years after a failure of world leaders to continue to support reproductive rights, according to Mary Robinson," former president of Ireland and a member of the Elders group, the Guardian reports in its series "The Politics of Family Planning."
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced the pricing of its initial public offering of 8 million shares of common stock at $5.00 per share. All of the common stock will be sold by AcelRx.
Halozyme Therapeutics has announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Cumulase for the treatment of oocytes to facilitate certain in vitro fertilization (IVF) procedures. The active pharmaceutical ingredient in Cumulase is the first and only recombinant human hyaluronidase approved in the United States for cumulus removal in the IVF process.
The research, presented at the European Society of Human Reproduction and Embryology annual conference, which ends today in Geneva, Switzerland, describes for the first time the use of an experimental technique that has made it possible to analyze the functioning of human sperm in contact with the cytoplasmic content of the eggs in vitro.
› Verified 7 days ago